Mesa Labs director gets 2,784 shares from RSUs
Mesa Laboratories director Mark Christopher Capone reported the vesting and exercise of 2,784 Restricted Stock Units into an equal number of shares of common stock on August 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mesa Laboratories director Mark Christopher Capone reported the vesting and exercise of 2,784 Restricted Stock Units into an equal number of shares of common stock on August 15, 2026. The derivative RSU position was reduced to zero in this transaction, and his directly held common stock position increased to 6,213 shares.
Insider Trade Summary
2,784 shares exercised/converted
Exercise
2 txns
Insider
Capone Mark Christopher
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units - 3 F1, F2, F3 | 2,784 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,784 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units - 3 — 0 contracts (Direct);
Common Stock — 6,213 shares (Direct)
Footnotes (3)
- F1. Each RSU represents a contingent right to receive one share of the Issuer's common stock
- F2. RSUs that vested on August 15, 2026
- F3. Not Applicable
Key Figures
RSUs Exercised: 2,784 shares
Common Shares Acquired: 2,784 shares
Common Shares Held After: 6,213 shares
+2 more
5 metrics
RSUs Exercised
2,784 shares
Restricted Stock Units converted into common stock on August 15, 2026
Common Shares Acquired
2,784 shares
Common stock received from RSU vesting and exercise on August 15, 2026
Common Shares Held After
6,213 shares
Directly held Mesa Laboratories common stock following the reported transactions
RSU Transaction Price
$0.0000 per share
Exercise/conversion of RSUs reported with a per-share transaction price of 0.0000
Exercise Transactions Count
1
Transaction summary lists one derivative exercise/conversion (code M)
Key Terms
Restricted Stock Units, derivative security, acquired_disposed_code, direct or indirect ownership
4 terms
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
acquired_disposed_code financial
"transaction_direction_source: acquired_disposed_code"
direct or indirect ownership financial
"direct_or_indirect uses D/I for Direct/Indirect ownership type"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MLAB director Mark Christopher Capone report in this Form 4?
He reported the vesting and exercise of 2,784 Restricted Stock Units into 2,784 shares of Mesa Laboratories common stock, leaving him with 6,213 common shares held directly after the transactions.
How many Mesa Laboratories (MLAB) RSUs vested for Mark Christopher Capone?
A total of 2,784 RSUs vested for Mark Christopher Capone. Each RSU represents a contingent right to receive one share of Mesa Laboratories common stock, and these RSUs vested on August 15, 2026.
What is Mark Christopher Capone’s Mesa Laboratories (MLAB) shareholding after this filing?
Following the reported transactions, Mark Christopher Capone directly holds 6,213 shares of Mesa Laboratories common stock. This reflects the addition of 2,784 shares received upon the vesting and conversion of RSUs.
Was there a net buy or sell of Mesa Laboratories (MLAB) stock in this Form 4?
There was no net market buy or sell reported. The filing shows an RSU derivative position disposed of and an equal number of common shares acquired, resulting in a netBuySellDirection of neutral in the transaction summary.
On what date did the reported Mesa Laboratories (MLAB) RSUs vest and convert?
The RSUs vested and were exercised into common stock on August 15, 2026. Footnotes specify that these RSUs vested on that date and that each RSU corresponds to one share of Mesa Laboratories common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
